Editorial Comment from Dr Hayakawa and Dr Kikuchi to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study)
- PMID: 35368133
- DOI: 10.1111/iju.14888
Editorial Comment from Dr Hayakawa and Dr Kikuchi to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study)
Comment on
-
Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).Int J Urol. 2022 Jul;29(7):632-638. doi: 10.1111/iju.14854. Epub 2022 Mar 15. Int J Urol. 2022. PMID: 35293022 Free PMC article.
References
-
- Matsumoto H, Shiraishi K, Azuma H et al. Clinical practice guidelines for bladder cancer 2019 update by the Japanese Urological Association: summary of the revision. Int. J. Urol. 2020; 27: 702-9.
-
- Cumberbatch MGK, Foerster B, Catto JWF et al. Repeat transurethral resection in nonmuscle-invasive bladder cancer: a systematic review. Eur. Urol. 2018; 73: 925-33.
-
- Kobayashi K, Matsuyama H, Kawai T et al. Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study). Int. J. Urol. 2022; 29: 632-8.
-
- Mostafid H, Babjuk M, Bochner B et al. Transurethral resection of bladder tumour: the neglected procedure in the technology race in bladder cancer. Eur. Urol. 2020; 77: 669-70.